Introduction {#sec1}
============

Treatment success of paediatric cancers has considerably increased over recent years, but as a consequence, male childhood cancer survivors often experience long-term comorbidities including infertility ([@ref37]; [@ref25]). Oncological treatments involving chemotherapeutic agents and radiation can severely impair the gonads by direct damage to the spermatogonial population, which represents the basis for spermatogenesis ([@ref33]; [@ref14]; [@ref37]; [@ref1]). The extent of damage and consequent risk of infertility later in life substantially depends on treatment type and duration and received dosage ([@ref33]; [@ref23]; [@ref36]). Prepubertal boys at risk of fertility impairment should be considered for fertility preservation strategies prior to receiving gonadotoxic treatment. Because of the absence of mature gametes, the current option to preserve fertility potential of these patients relies on cryopreservation of a testicular biopsy harbouring unharmed spermatogonial stem cells (SSCs) ([@ref1]; [@ref26]).

Cryopreservation of testicular tissue is increasingly offered in various specialized centres worldwide, whereas fertility restoration strategies to derive sperm from cryopreserved immature human testicular biopsies remain under development ([@ref26]). In animal models including rodents and non-human primates, a number of potential techniques are being investigated and production of sperm and/or offspring has already been proven following autologous SSC transplantation ([@ref3]; [@ref11]), testicular tissue grafting ([@ref13], [@ref12]; [@ref20]; [@ref35]; [@ref24]; [@ref9]) and *in vitro* spermatogenesis by organ culture ([@ref30], [@ref32]).

In 2011, Sato and colleagues reported for the first time successful *in vitro* differentiation of fresh murine neonatal spermatogonia into functional sperm by employing an organ culture method ([@ref30], [@ref32]). This approach, consisting of culturing small testicular fragments positioned on a supportive stand at the gas--liquid interface, was later applied to cryopreserved neonatal mice testicular tissue ([@ref39]; [@ref8]) and adult mice testicular tissue ([@ref31]). Despite the encouraging results, generation of sperm *in vitro* from human prepubertal testicular tissue has not yet been accomplished ([@ref6]; [@ref22]). Furthermore, to become clinically applicable, the organ culture method has to be successfully applied to cryopreserved testicular material as tissue cryopreservation is a routine element in fertility preservation strategies.

This study aimed to determine whether the organ culture method can be applied to fresh and cryopreserved human (pre)pubertal testicular tissue as a strategy for *in vitro* spermatogenesis. To examine if the low success of human (pre)pubertal testicular organ culture ([@ref6]; [@ref22]) was due to cryopreservation-induced damaged to the tissue, we compared functionality of fresh and cryopreserved-thawed tissue in culture medium without or supplemented with FSH and LH.

Materials and Methods {#sec2}
=====================

Ethical approval {#sec3}
----------------

Testicular tissue was collected from 9 (pre)pubertal boys (6--14 years, [Table I](#TB6){ref-type="table"}) admitted at the Academic Medical Center (Amsterdam, The Netherlands) for fertility preservation procedure prior to gonadotoxic cancer treatment. For all cases, ethical approval (NL27690.000.09) was obtained from the National Ethical Committee (CCMO), and informed consent was received from patients' parents for using a portion of the testicular biopsy for research purposes.

###### 

Baseline and histological characteristics of testicular tissues collected from nine (pre) pubertal patients.

  **Organ culture code**                        **Age (years)**   **Diagnosis**                          **Testicular histology before culture**               
  --------------------------------------------- ----------------- -------------------------------------- ----------------------------------------- ----- ----- ----------
  OCID22^[\*](#tblfn4){ref-type="table-fn"}^    6                 Rhabdomyosarcoma                       Spermatogonia                             2.6   Yes   No
  OCID30                                        8.5               Intracranial, spinal embryonal tumor   Spermatogonia                             2.7   Yes   No
  OCID25                                        9                 Lymphocytic leukemia                   Spermatogonia                             2.4   Yes   No
  OCID23                                        10                Rhabdomyosarcoma                       Spermatogonia                             2.3   Yes   Dim
  OCID24                                        10                Glioma                                 Spermatogonia                             2.9   Yes   No
  OCID27                                        10.5              Anaplastic Large Cell Lymphoma         Spermatogonia                             2.9   Yes   No
  OCID29 ^[\*](#tblfn4){ref-type="table-fn"}^   11                Rhabdomyosarcoma                       Few spermatogonia (\<25%)                 2.2   Yes   No
  OCID26 ^[\*](#tblfn4){ref-type="table-fn"}^   12                Intracranial, spinal embryonal tumor   Few spermatogonia (\<25%)                 2.2   Yes   No
  OCID28                                        14                M. Hodgkin                             Elongating spermatids                     6.0   No    Moderate

^\*^Testicular histological characteristics evaluated in cryopreserved-thawed tissue.

^\#^Calculation of average Johnsen score ([@ref16]) is described in [Supplementary Table SI](#sup2){ref-type="supplementary-material"}.

Testicular tissue collection and cryopreservation {#sec4}
-------------------------------------------------

Patients underwent open testicular biopsy during deep venous catheter insertion with general anaesthesia. The main part of each biopsied testicular tissue was cryopreserved and stored for potential future clinical application and a portion of \~15% was used for research. Biopsied testicular tissue for research was either immediately processed or first cryopreserved before organ culture ([Fig. 1](#f1){ref-type="fig"}). Cryopreservation of testicular fragments was performed following a slow freezing protocol as previously described ([@ref18]). Briefly, testicular biopsies were cut into small fragments and preserved in straws with 5% dimethyl sulfoxide (Cryosure---DMSO; WAK Chemie Medical GmbH, Germany) and 5% albumin (Albuman; Sanquin, The Netherlands) in human tubal fluid-HEPES (Gynotec bv., The Netherlands). Samples were stored in vapour phase nitrogen and used for research between 0.5 and 2 months after freezing.

![**Schematic overview of the experimental design.** Biopsied testicular tissue for research was immediately processed or first cryopreserved in straws before organ culture. Testis fragments (1--2 mm^3^) were cultured on top of agarose stands for a maximum of 5 weeks (34°C, 5% CO~2~) in two different media without (medium I) or with hormonal supplementation (medium II).](dez180f1){#f1}

Organ culture of testicular tissue {#sec5}
----------------------------------

Cryopreserved tissue samples were thawed and immediately washed three times in Minimum Essential Medium alpha (α-MEM; 22561-021, Thermo Fisher Scientific, USA) on ice before being further processed for culture.

Fresh or cryopreserved-thawed testis fragments were processed into 1--2 mm^3^ pieces. Prior to initiation of culture, one fragment was fixed in modified methacarn (89% methanol and 11% glacial acetic acid) for 3 hours at room temperature (RT) ([@ref15]). The remaining fragments were divided into two groups for culture in two media: culture medium I was composed of α-MEM + 10% knock-out serum replacement (KSR; 10828-028, Thermo Fisher Scientific, USA) + 1% penicillin-streptomycin (15140122, Thermo Fisher Scientific, USA) supplemented with 10^−7^ M melatonin (M5250, Sigma-Aldrich, Germany) and 10^−6^ M retinoic acid (R2625, Sigma-Aldrich, Germany) and culture medium II consisted of culture medium I with the addition of 3 IU/L FSH/LH (Menopure 75 IE, Ferring B.V., The Netherlands) ([Fig. 1](#f1){ref-type="fig"}). Testicular fragments were placed on top of 0.35% (w/v) agarose (seaKem LE; 50004, Lonza, Switzerland) stands according to the gas--liquid interphase method. Agarose stands were prepared by mixing equal volumes of pre-autoclaved 0.7% (w/v) agarose with culture medium. After solidification, agarose stands were cut and transferred into 6-well plates. Each agarose stand was loaded with up to three fragments, and the culture medium was adjusted to the edge of the stand without covering the testicular fragments ([@ref28]). To focus on early events crucial for spermatogenesis initiation and further progress *in vitro* (cell viability, meiosis initiation and somatic differentiation), testicular pieces were cultured for a maximum period of 5 weeks ([Table II](#TB7){ref-type="table"}; [Supplementary Table SII](#sup2){ref-type="supplementary-material"}) at 34°C and 5% CO~2~. Culture media were renewed weekly, and supernatants were collected. Depending on the initial biopsy size, a minimum of three cultured pieces were weekly fixed in modified methacarn and paraffin (ParaPlast Plus---39602004; Leica Biosystems, Germany) embedded.

###### 

Detailed information on culture period (weeks) and total number of cultured testicular fragments analysed for each (pre)pubertal patient.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Organ culture code   Age (years)   Time points of analysis\   Total number\                                                                                    
                                     (weeks)                    of fragments (detailed in [Supplementary Table SII](#sup2){ref-type="supplementary-material"})   
  -------------------- ------------- -------------------------- ------------------------------------------------------------------------------------------------ ----
  OCID22               6             2, 4, 5                    0, 2, 4, 5                                                                                       40

  OCID30               8.5           0, 1, 2, 4, 5              0, 1, 2, 4, 5                                                                                    48

  OCID25               9             0, 2, 4                    0, 2, 4                                                                                          25

  OCID23               10            0 to 5                     0, 1, 2, 4, 5                                                                                    54

  OCID24               10            0 to 5                     0, 1, 2, 4, 5                                                                                    56

  OCID27               10.5          0, 2, 4, 5                 0, 2, 4, 5                                                                                       35

  OCID29               11            2, 4, 5                    0, 2, 4, 5                                                                                       38

  OCID26               12            1 to 5                     1, 2, 4, 5                                                                                       56

  OCID28               14            0 to 5                     0 to 5                                                                                           62
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

Depending on initial biopsy size, the number of cultured fragments and distribution throughout culture conditions and time points of analysis were variable between patients. Due to tissue scarcity, solely for one patient (OCID28) were all culture conditions evaluated at week 3.

Immunohistochemistry {#sec6}
--------------------

To characterize pre-culture tissue and assess the effect of culture conditions on testicular fragments, several immunohistochemical stainings were performed on 5 μm sections. After deparaffinization, antigen retrieval was performed, if necessary, in 0.01 M sodium citrate buffer (pH 6.0) in a microwave for 10 minutes. Endogenous peroxidases were inactivated with 0.3% H~2~O~2~ and nonspecific adhesion sites blocked with suitable blocking solution ([Supplementary Table SIII](#sup4){ref-type="supplementary-material"}) for 1 hour at RT. Sections were subsequently incubated overnight at 4°C with mouse monoclonal primary antibodies ([Supplementary Table SIII](#sup4){ref-type="supplementary-material"}) for anti-MAGEA4 (1:100; kindly provided by Prof. Spagnoli) as a spermatogonial marker, anti-PCNA (1:200; ab92552, Abcam, UK) as a proliferation marker, anti-γ-H2AX (1:20 000; 05-636, Millipore, USA) as meiotic marker, anti-AMH (1:100; sc-166 752, Santa Cruz Biotechnology, USA) as immature Sertoli cell marker or anti-AR (1:100; SC-7305, Santa Cruz Biotechnology, USA) as mature Sertoli cell marker. After washes in PBS, sections were incubated with secondary antibody Poly-HRP-Goat anti Ms/Rb/Rt IgG (DPVO110HRP, Immunologic BV, The Netherlands). Signal was visualized with 3,3′-diaminobenzidine (Bright-DAB; BS04, Immunologic BV, The Netherlands).

Proliferating spermatogonia were recognized with anti-MAGEA4 and anti-PCNA double staining following the manufactures protocol (Polink DS-MR-Hu D1 kit, DS201D-18, GBI Labs, USA). MAGEA4 and PCNA signals were visualized with DAB and fast-red chromogens, respectively.

For all stainings, negative controls were performed using isotype IgG in corresponding concentrations. All sections were counterstained with Mayer's haematoxylin.

Stained sections were entirely scanned using Philips IntelliSite UFS slide scanner (Philips Digital Pathology Solutions, The Netherlands) at 40× magnification.

Intratubular cell apoptosis {#sec7}
---------------------------

For histological identification of apoptotic cells, a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay was performed on sections of cultured and uncultured testicular fragments according to the manufacturer's protocol (*In Situ* Cell Death Detection Kit, 11684817910, Roche Diagnostics, The Netherlands), with the enzyme solution diluted 1:100 in PBS. Positive controls were established on adult human testis sections treated with 2 mg/mL DNAse, while sections processed without enzyme solution in the TUNEL reaction mix were used as negative controls. Visualization of apoptotic cells was done using DAB as a chromogen, and sections were counterstained with Mayer's haematoxylin.

Characterization of the cultured testicular tissue fragments {#sec8}
------------------------------------------------------------

All testicular fragments were evaluated for the presence of the most advanced germ cell and (immuno)histochemical detection of spermatogonia, proliferative status of spermatogonia and Sertoli cells, intratubular cell apoptosis and maturation status of Sertoli cells. Germ and Sertoli cells were identified based on morphological nuclear criteria and location within the seminiferous epithelium ([@ref4]).

For each staining, semi-quantitative analysis on up to five fragments per condition and time point ([Supplementary Table SII](#sup3){ref-type="supplementary-material"}) was blindly assessed on two cross-sections of every fragment ([Supplementary Table SIV](#sup5){ref-type="supplementary-material"}) with at least 20 μm interval distance assuring evaluation of independent cells. Due to tissue scarcity, enough fresh and cryopreserved material was available to perform experiments at all culture conditions at week 3 for only one patient (OCID28) ([Table II](#TB7){ref-type="table"}; [Supplementary Table SII](#sup3){ref-type="supplementary-material"}).

All tubular cross-sections were counted, and the results for each marker were expressed as the ratio between the number of tubules with at least one positive cell and the total number of tubules. A total of 370--1145 tubular cross-sections were evaluated per patient for MAGEA4/PCNA double-stained sections, 469--1064 for AMH and 690--1199 for TUNEL ([Supplementary Table SIV](#sup5){ref-type="supplementary-material"}).

Results for each patient and culture condition were individually represented in R (version 3.4.0) using the *ggplot2* package. The boxplot displays the median and first and third quartiles (25th and 75th percentiles) of all patients at each time point in culture. Where relevant, the cohort was divided into patients with complete spermatogenesis (Johnsen score 6) and those with spermatogonia as the most advanced germ cell type (Johnsen score 2--3).

Measurement of testosterone secretion to culture media {#sec9}
------------------------------------------------------

Culture supernatants were weekly collected and stored at −20°C until further use. Testosterone levels in culture supernatants were measured in duplicate using Parameter Testosterone Immunoassay (SKGE010/KGE010, R&D Systems, USA) following the manufacturers protocol. Concentrations (ng/mL) were calculated according to the optical density at 450 and 560 nm (microplate reader Multiskan EX, Thermo Fisher Scientific, Finland) compared to a standard curve. The sensitivity of the assay was 0.03 ng/mL with intra- and inter-assay coefficients of variation of \<5% and \<10%, respectively.

Calculated values were normalized by the number of fragments present in the culture wells at time of supernatants collection. The results are presented as the mean ± SE of all patients at each time point in culture.

Statistical analyses {#sec10}
--------------------

Statistical analyses were performed in SPSS Statistics for Windows, Version 22.0 (IBM Corp., USA). The influence of culture media, initial state of the tissue (fresh versus cryopreserved) and culture period on the functional parameters of testicular fragments (spermatogonial survival and proliferation, intratubular cell apoptosis, Sertoli cell maturation and proliferation) were determined by a mixed-effect linear model, with variables considered as fixed effects. Interaction effect between the variables, culture media, initial state of the tissue (fresh versus cryopreserved) and culture period, was always analysed but removed from the model when not significant (*P* \> 0.05).

For evaluation of testosterone concentration in the various culture conditions and throughout culture period, three-way ANOVA for repeated measurements followed by Bonferroni tests were performed.

Differences were considered significant for a *P*-value of \<0.05. No outliers were excluded.

Results {#sec11}
=======

Testicular tissue maturation status before culture {#sec12}
--------------------------------------------------

Testicular tissues collected from nine patients, who were admitted for fertility preservation procedure before gonadotoxic treatment, showed histological heterogeneity concerning the most advanced germ cell content and Sertoli cells maturation status. A prepubertal status was demonstrated in the majority of boys (ages between 6 and 12 years old), with spermatogonia being the only germ cell type present in the seminiferous tubules, without evidence of initiation of spermatogenesis (Johnsen score 2--3; [Supplementary Table SI](#sup2){ref-type="supplementary-material"}). There is only one patient of 14 years of age (OCID28), and he showed complete spermatogenesis, with all germ cell types constituting the seminiferous epithelium (Johnsen score 6; [Supplementary Table SI](#sup2){ref-type="supplementary-material"}). For all patients without spermatogenesis progression, Sertoli cells were still immature, as observed by the expression of AMH. However, patient OCID23 showed simultaneous expression of AMH and dim expression of AR, suggesting an intermediate maturation phenotype. When spermatogenesis was already ongoing (patient OCID28), a mature state of Sertoli cells was confirmed by the absence of expression of AMH and moderate expression of AR ([Table I](#TB6){ref-type="table"}).

Most advanced germ cell type after organ culture {#sec13}
------------------------------------------------

For all prepubertal patients with spermatogonia as the most advanced germ cell type in the biopsied testicular tissue, organ culture failed to induce spermatogonial differentiation, irrespectively of the conditions tested. The results were confirmed morphologically and by the absence of immunohistochemical staining of the meiotic marker γ-H2AX (data not shown). For the pubertal patient (OCID28), γ-H2AX expression was lost after 1 week in organ culture (data not shown). Additionally, spermatogenesis was not maintained *in vitro* and, in fact, depletion of more differentiated layers of the seminiferous epithelium and tubular sclerosis was evident throughout culture while elongating spermatids were maintained for 5 weeks ([Supplementary Fig. S1a](#sup1){ref-type="supplementary-material"}).

Spermatogonial survival during testicular culture {#sec14}
-------------------------------------------------

Based on MAGEA4 immunohistochemical evaluation, spermatogonia survived *in vitro* throughout the culture period of 5 weeks ([Fig. 2a](#f2){ref-type="fig"}). However, quantitative analysis revealed a statistically significant reduction (*P* ≤ 0.001) in the percentage of seminiferous tubules containing at least one MAGEA4 positive cell during culture.

![**Spermatogonia present in testicular fragments cultured for 5 weeks. (a)** Immunohistological identification of MAGEA4 (brown) spermatogonia in a MAGEA4/PCNA (pink) double staining. Scale bars: black = 50 μm; grey = 100 μm. **(b)** Percentage of seminiferous tubules containing at least one MAGEA4-positive cell in fresh (pink) and cryopreserved (blue) testicular fragments cultured in medium without (medium I; faint colour) or with FSH/LH supplementation (medium II; dark colour). Single dots represent results from individual patients, and the boxplot displays the median and 25th and 75th percentiles of all patients at each time point in culture. Mixed-effect linear model revealed a statistically significant reduction (*P* ≤ 0.001) during culture.](dez180f2){#f2}

Spermatogonial survival was comparable between fresh and cryopreserved cultured fragments and was independent of the culture medium hormonal supplementation ([Fig. 2b](#f2){ref-type="fig"}).

Spermatogonial proliferation during testicular culture {#sec15}
------------------------------------------------------

The percentage of tubules containing at least one cell simultaneously expressing MAGEA4 and PCNA ([Fig. 3a](#f3){ref-type="fig"}) was used as the spermatogonial proliferation index. Despite spermatogonia remained proliferative *in vitro*, a significant decrease in the percentage of tubules containing at least one proliferating spermatogonia was observed throughout culture (*P* ≤ 0.001). Furthermore, no statistical difference in tubular cross-sections with proliferating spermatogonia was observed between fresh and cryopreserved cultured fragments nor between the two culture media tested ([Fig. 3b](#f3){ref-type="fig"}).

![**Proliferation status of spermatogonia and Sertoli cells in testicular fragments cultured for 5 weeks. (a)** Double immunohistochemical staining of MAGEA4 and PCNA. Proliferative spermatogonia were identified by simultaneous expression of MAGEA4 and PCNA while proliferative Sertoli cells (SCs) were morphologically identified. Black arrow, PCNA-negative spermatogonia; white arrow, PCNA-positive spermatogonia; black arrowhead, PCNA-negative SCs; white arrowhead, PCNA-positive SCs. Scale bar = 10 μm. Percentage of seminiferous tubules containing at least one proliferative (**b)** spermatogonia or (**c)** SCs in fresh (pink) and cryopreserved (blue) testicular fragments cultured in medium without (medium I; faint colour) or with FSH/LH supplementation (medium II; dark colour). Single dots represent results from individual patients, and the boxplot displays the median and 25th and 75th percentiles of all patients at each time point in culture. Mixed-effect linear model revealed a statistically significant reduction (*P* ≤ 0.001) during culture.](dez180f3){#f3}

Fragments initially containing elongating spermatids (OCID28) showed less proliferation of spermatogonia in testicular tissue culture, becoming absent after 1 week in medium with FSH/LH (Medium II) and after 2 weeks in medium without hormonal supplementation (Medium I) ([Supplementary Fig. S1a and b](#sup1){ref-type="supplementary-material"}).

Sertoli cells proliferation during testicular culture {#sec16}
-----------------------------------------------------

Sertoli cells were morphologically identified and proliferation activity was determined by immunohistochemical expression of PCNA ([Fig. 3a](#f3){ref-type="fig"}). An increase of Sertoli cells proliferative activity was evident after one week of testicular culture, followed by a decrease and stabilization, even though no statistical significance was reached due to the non-linear behaviour of repeated measurements. In fact, for the overall culture period, a significant decrease (*P* ≤ 0.001) in the percentage of tubules with at least one proliferating Sertoli cell was observed ([Fig. 3c](#f3){ref-type="fig"}).

Although average Sertoli cell proliferation was higher in testicular fragments that had been cryopreserved before culture compared to freshly cultured fragments, the values were not statistically different for the global culture period. Additionally, no statistical difference was detected between the two culture media tested.

Intratubular cell apoptosis {#sec17}
---------------------------

Intratubular cell apoptosis was considered since morphological distinction between TUNEL-positive spermatogonia or Sertoli cells was hampered by compromised morphological integrity of the apoptotic cell nucleus. A significant increase (*P* ≤ 0.001) in the percentage of intratubular apoptosis was observed with culture. Intratubular cell apoptosis was comparable between fresh and cryopreserved cultured fragments and independent of the culture media tested ([Fig. 4](#f4){ref-type="fig"}).

![**Intratubular cell apoptosis in testicular fragments cultured for 5 weeks. (a)** TUNEL staining (brown). Scale bars: black = 50 μm; grey = 100 μm. **(b)** Percentage of intratubular cell apoptosis in fresh (pink) and cryopreserved (blue) testicular fragments cultured in medium without (medium I; faint colour) or with FSH/LH supplementation (medium II; dark colour). Single dots represent results from individual patients, and the boxplot displays the median and 25th and 75th percentiles of all patients at each time point in culture. Mixed-effect linear model revealed a statistically significant increase (*P* ≤ 0.001) during culture.](dez180f4){#f4}

Maturation status of Sertoli cells during testicular culture {#sec18}
------------------------------------------------------------

Sertoli cell maturation status was verified by AMH and AR immunohistochemical expression.

In the pubertal patient OCID28 (Johnsen score 6), AMH expression remained undetectable in culture. If expressed in testicular tissues before culture ([Table I](#TB6){ref-type="table"}), a statistically significant decrease in the number of tubules containing AMH-expressing Sertoli cells was observed during culture ([Fig. 5](#f5){ref-type="fig"}). However, testicular tissue culture never promoted AR expression by Sertoli cells (data not shown). In fact, when AR was expressed in testicular tissues before culture (OCID23 and OCID28), this expression was lost during the first week of organ culture (data not shown). The Sertoli cell AMH and AR expression patterns in organ culture were independent of FSH/LH addition to the culture medium and identical between fresh and cryopreserved fragments.

![**Maturation status of Sertoli cells present in testicular fragments cultured for 5 weeks. (a)** AMH (brown) immunohistochemistry. Scale bars: black = 50 μm; grey = 100 μm. **(b)** Percentage of seminiferous tubules containing AMH-positive SCs in fresh (pink) and cryopreserved (blue) testicular fragments cultured in medium without (medium I; faint colour) or with FSH/LH supplementation (medium II; dark colour). Single dots represent results from individual patients, and the boxplot displays the median and 25th and 75th percentiles of all patients at each time point in culture. Mixed-effect linear model revealed a statistically significant reduction (*P* ≤ 0.001) during culture.](dez180f5){#f5}

Testosterone production *in vitro* {#sec19}
----------------------------------

Testosterone levels, indicating the functionality of Leydig cells present in cultured testicular fragments, showed a significant increase in culture (*P* ≤ 0.02), particularly from culture week 1 to week 3 (*P* ≤ 0.05), followed by a stabilization from week 4 onwards ([Fig. 6](#f6){ref-type="fig"}). Testosterone concentrations in medium supplemented with FSH/LH showed a trend towards higher values, but these were not statistically different. Furthermore, for the overall culture period, no statistical difference was observed between testosterone production levels from fresh and cryopreserved cultured fragments. Interestingly, for the pubertal patient with complete spermatogenesis (OCID28), any of the culture conditions sustained Leydig cells' functionality, as testosterone was constantly maintained at low levels (ranging from 0.12 and 1.9 ng/mL) during the complete culture period ([Supplementary Fig. S1c](#sup1){ref-type="supplementary-material"}).

![**Concentration (ng/mL) of testosterone secreted by fresh (pink) and cryopreserved (blue) testicular fragments during 5 weeks organ culture in medium without (medium I; faint colour) or with FSH/LH supplementation (medium II; dark colour).** Data are presented as mean ± SE and ^\*^*P* \< 0.05.](dez180f6){#f6}

Discussion {#sec20}
==========

Although attempts to achieve *in vitro* spermatogenesis using cryopreserved human prepubertal testicular tissue have been reported ([@ref7], [@ref6]; [@ref22]), to our knowledge this is the first report evaluating and comparing the functionality of fresh and cryopreserved testicular fragments in organ culture. *In vitro* initiation of spermatogenesis was not achieved in either fresh or cryopreserved immature testicular tissue in two different media conditions. Our data do suggest that fresh and cryopreserved prepubertal testicular fragments have comparable functionality in the described culture conditions, as reflected by the absence of significant differences in any of the weekly evaluated functional parameters: spermatogonial survival and proliferation, intratubular cell apoptosis, Sertoli cell maturation and proliferation and testosterone production by Leydig cells.

An indication of where a potential improvement might lie in developing the *in vitro* testicular organ culture system for the human tissue comes from two recent papers ([@ref6]; [@ref22]). de Michele and colleagues reported the development of meiotic and postmeiotic cells after 16 days in organ culture of human cryopreserved testicular tissues ([@ref6]). In their experiments, the culture media was supplemented with a physiological serum concentration of FSH and the authors claimed that this was essential for meiosis initiation in immature human cryopreserved testicular organ culture ([@ref7], [@ref6]). Likewise, in an FSH and LH supplemented media, Medrano *et al*. observed signs of spermatogenesis initiation followed by a block in maturation at a premeiotic stage ([@ref22]).

Different outcomes observed between previous studies and ours might be explained by the culture media composition (compared in [Supplementary Table SV](#sup2){ref-type="supplementary-material"}). Furthermore, the use of different cryopreservation protocols, involvement of distinct cohorts including patients with various initial maturation states, ages and different cancer diagnoses with unknown consequences for testicular function and differentiation potential *in vitro* are important factors to consider when explaining the differences in outcome between studies. Nevertheless, complete spermatogenesis was never achieved and progressive germ cell loss was evident in all studies ([@ref6]; [@ref22]). Therefore, the functionality and ability of cryopreserved human prepubertal testicular tissue to complete spermatogenesis remain to be demonstrated.

In our study, some spermatogonia survived and remained proliferative active in all culture conditions; however, a substantial decrease of the spermatogonial numbers was observed over culture time, possibly justified by the combination of reduced proliferation activity and increased intratubular cell apoptosis. This was accompanied by a failed induction or maintenance (depending on maturation status before culture) of Sertoli cell maturation and a transient increase in Sertoli cell proliferative activity *in vitro*. While a decline in AMH expression suggested maturation of Sertoli cells *in vitro*, the culture conditions tested in this study did not support normal maturation of Sertoli cells as evidenced by the absence of AR expression. Discordant indications of Sertoli cells maturation status demonstrated by proliferative activity, AMH and AR expression might be suggestive of Sertoli cell dysfunction ([@ref34]). Similar observations were previously reported demonstrating a reduction in AMH expression and secretion, while AR expression results were inconclusive ([@ref7], [@ref6]; [@ref22]). Furthermore, establishment of a blood--testis barrier by adjacent Sertoli cells (indicative of differentiated state) was reported to be solely partially achieved or maintained in organ culture as revealed by expression analysis of tight and gap junctions proteins ([@ref5]).

These results suggest that the current organ culture conditions are unable to support correct Sertoli cell maturation in prepubertal testicular tissue, a consequence of which might be germ cells loss and incapability to support complete progression of human spermatogenesis ([@ref17]).

Since the recovery of fertility potential of cryopreserved tissue has still not been proven in humans, the cryopreservation protocol remains experimental and may require improvements to ensure the ability of tissue to complete spermatogenesis by organ culture ([@ref26]). Although no differences between fresh and cryopreserved testicular tissue were noticeable in this study, we cannot exclude that if an optimized culture method ensuring complete spermatogenesis is established, functional or spermatogenic efficiency differences between fresh and cryopreserved tissue might be found.

A direct translation of the organ culture conditions established in mice to other animal models failed to result in identical spermatogenic outcomes. In fact, further adaptations of the culture media have not yet resulted in full spermatogenesis from immature spermatogonia in rats nor in humans ([@ref29]; [@ref7], [@ref6]; [@ref22]). Attempting to better mimic the human pubertal testicular niche *in vivo* by stimulating spermatogonia self-renewal and differentiation as well as somatic cells maturation, we tried to further refine the culture media with retinoic acid and melatonin (medium I) as well as additional supplementation with FSH and LH (medium II). *In vivo* and *in vitro* studies in rodents have shown that retinoic acid is an essential factor for germ cell differentiation and maintenance ([@ref38]; [@ref19]; [@ref2]) and melatonin is known to prevent tissue damage induced by reactive oxygen or nitrogen species due to cytotoxic exposure ([@ref21]; [@ref10]). Although the testicular architecture was maintained in cultured testicular fragments, medium I (containing retinoic acid and melatonin) was not enough to stimulate initiation of spermatogenesis *in vitro*. FSH and LH are gonadotrophins known to play a key role in testicular maturation and germ cell development. While LH acts on Leydig cells stimulating testosterone production and consequently inducing testicular maturation, FSH supports spermatogenesis via effects on Sertoli cells metabolism ([@ref27]). Our results show that, for all of the functional parameters (spermatogonial survival and proliferation, intratubular cell apoptosis, Sertoli cell maturation, and proliferation) evaluated on fresh and cryopreserved cultured testicular fragments, medium supplementation with LH and FSH (medium II) did not induce significant improvements compared to non-supplemented medium (medium I). Even so, Leydig cells endocrine function was stimulated in all culture conditions, with no difference reflected in testosterone production in medium supplemented with FSH/LH (medium II) compared to non-supplemented medium (medium I).

The initial maturation status of the testicular tissues might also have considerable influence on the efficiency of the organ culture. In fact, Sato *et al.* clearly described lower spermatogenic efficiency of organ culture of adult mouse testicular fragments when compared to neonatal tissue ([@ref31]). Although not statistically confirmed, Medrano *et al.* observed a lower number of conserved testicular tubules after organ culture from samples with a more advanced maturation stage (Johnsen score 6--8), suggesting a higher sensitivity of the testicular tissue at a more advanced stage of spermatogenesis to *in vitro* conditions ([@ref22]). In our study, the histological maturation state of the testicular tissues was homogenous with spermatogonia as the most advanced germ cell type, except for one patient who had complete spermatogenesis. Interestingly, and in accordance with the literature, in the pubertal patient (OCID28; Johnsen score 6), the somatic environment was greatly affected by culture as observed by the extremely low concentration of testosterone production and increased tissue sclerosis. However, due to the limited number of patients with complete spermatogenesis included in this study, further comprehensive analysis should be done to confirm this hypothesis.

The different steps of germ cell development are dependent on the appropriate hormonal environment that fluctuates through (pre)puberty. In this study, a single and constant concentration of gonadotropins was used for all patients, independently of their initial maturation status. In fact, it might be that these tissues have different hormonal requirements and culture conditions depending on patients' testicular development.

Concluding, we reported that the current testicular organ culture system supports, both for fresh and for cryopreserved tissue, maintenance of the testicular architectural structure, spermatogonial proliferation and endocrine function but does not induce spermatogenesis. As testicular cryopreservation is actively offered to prepubertal cancer patients, this study highlights the necessity for further improvement of the current organ culture method to become clinically applicable, ensuring better spermatogonial survival as well as differentiation to sperm in cryopreserved testicular biopsies. Furthermore, the current inability to initiate spermatogenesis *in vitro* from cryopreserved testicular fragments should form part of the counselling of patients included in fertility preservation programmes.

Supplementary Material
======================

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

We thank Dr O.J. de Boer from the Department of Pathology (AMC), for support with the Philips IntelliSite UFS slide scanner, J. Eliveld from the Center of Reproductive Medicine (AMC), for assistance with testosterone measurements, and Dr M. van Wely from the Center of Reproductive Medicine (AMC), for advice on statistical analysis.

Authors' roles {#sec21}
==============

This study was designed by J.M.D.P., A.M.M.P. and S.R. Testicular tissue was biopsied by A.M. and cryopreserved by A.A.M. Experiments were done by J.M.D.P., S.K.M.D. and C.M.W.K. J.M.D.P. and A.M.M.P contributed for data acquisition, analysis and interpretation and drafting of the manuscript. All authors critically revised the manuscript and approved the final version.

Funding {#sec22}
=======

Growsperm (EU-FP7-PEOPLE-2013-ITN 603568).

Conflict of interest {#sec23}
====================

None of the authors have any competing interests to declare.
